Research progress on the key cuproptosis regulator FDX1 and its relevance to triple-negative breast cancer. [PDF]
Yuping F +4 more
europepmc +1 more source
The CP-STPG3-AS1 axis regulates lipoylation and cuproptosis in castration-resistant prostate cancer. [PDF]
He JW, Li PZ, Zhang ZZ.
europepmc +1 more source
Suppression of the cuproptosis mechanism by the oncogene <i>RASGRP2</i> in driving osteosarcoma progression. [PDF]
Chen J +7 more
europepmc +1 more source
Exploring Cuproptosis-Related Genes and Diagnostic Models in Renal Ischemia-Reperfusion Injury Using Bioinformatics, Machine Learning, and Experimental Validation [PDF]
Changhong Xu,1,* Yun Deng,1,* Xinyi Gong,2,* Huabin Wang,1 Jiangwei Man,1 Hailong Wang,1 Kun Cheng,1 Huiming Gui,1 Shengjun Fu,1 Shenghu Wei,3 Xiaoling Zheng,4 Tuanjie Che,4 Liyun Ding,3 Li Yang1 1Department of Urology, Institute of Urology ...
Fu S +12 more
core
Biochanin A Induces Cuproptosis and Inhibits Lung Metastasis in triple-negative Breast Cancer. [PDF]
Zhang L +10 more
europepmc +1 more source
Single-cell profiling reveals GABBR1 as a cuproptosis-regulated prognostic biomarker in pancreatic cancer. [PDF]
Gong J +9 more
europepmc +1 more source
Metal-Organic Framework-Based Nanomedicines for Cancer Therapy: A Proposed Delivery Framework for Executable Cuproptosis. [PDF]
Fu L +8 more
europepmc +1 more source
Integrated Single-Cell and Transcriptomic Analysis Suggests a Cuproptosis-Related Phenotype and Potential Therapeutic Target in Acute Pancreatitis. [PDF]
Xie Q, He M, Wang Q, Li W.
europepmc +1 more source
Cuproptosis-Related Genes as Prognostic Biomarkers for Sepsis: Insights into Immune Function and Personalized Immunotherapy [PDF]
Jun Zhang,1,* Yinyu Wu,1,* Yuanlin Du,1,* Yunxia Du,1 Daiqin Bao,1 Haibin Lu,2 Xiaoqiong Zhou,1 Rui Li,1 Haoyu Pei,1 Han She,1 Qingxiang Mao1 1Department of Anesthesiology, Daping Hospital, Army Medical University, Chongqing, 400042, People’s
Zhang J +9 more
core
Beyond gene signatures: a mechanism-based framework for cuproptosis susceptibility in non-small cell lung cancer at the metabolism-immunity interface. [PDF]
Liang Z +8 more
europepmc +1 more source

